ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

Vitiligo Signature-Based Drug Screening Identifies Fulvestrant as a Novel Immunotherapy Combination Strategy.

Jie Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.